US Justice Department Reclassifies Medical Cannabis to Schedule III: Implications for Research and Business
U.S. Congress Navigates Dual Cannabis Policy Shifts Affecting Industrial Hemp and Marijuana Rescheduling
Texas Judge Extends Pause on Smokable Hemp Ban, Citing Irreparable Harm to Industry
DEA Assigns New Drug Code to Hexahydrocannabinol (HHC), Reaffirming Schedule I Status
Texas Voters Show Overwhelming Support for Medical Cannabis Reforms, Poll Indicates
U.S. House Passes Farm Bill, Omitting Protections for Hemp-Derived Cannabinoid Industry
CAURD Inc. Outlines Plan to Stabilize New York's Equity Cannabis Market
Texas Industrial Hemp Industry Challenges State Ban on Smokable Products and Increased Licensing Fees
Potential US Federal Medical Cannabis Reclassification Could Reshape Market Dynamics for Marketers and Industry
Florida Regulators Address Alleged Environmental Violations at Trulieve Cultivation Site
